Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Feb 8;37(2):344-347.
doi: 10.1080/08998280.2023.2289301. eCollection 2024.

Tumefactive multiple sclerosis

Affiliations
Case Reports

Tumefactive multiple sclerosis

Bünyamin Tosunoğlu et al. Proc (Bayl Univ Med Cent). .

Abstract

Tumefactive multiple sclerosis (MS) is a subtype of atypical and rare MS that presents with tumor-like lesions in the central nervous system. The lesions may demonstrate a mass effect, edema, with ring enhancement. They can be mistaken for brain tumors or brain abscesses radiologically and clinically. Here we describe an instructive case of a 55-year-old woman with tumefactive MS who presented with occasional numbness in her right arm and leg, headache, thought confusion, and blurred vision for 2 years.

Keywords: Abscess; demyelinating; tumor.

PubMed Disclaimer

Conflict of interest statement

The authors report no funding or conflicts of interest. The patient provided consent for this case report to be published.

Figures

Figure 1.
Figure 1.
Lesions consistent with tumefactive multiple sclerosis were noted on MRI diffusion sequence of the (a) right periventricular region and (b) left half of the mesencephalon. (c) Diffusion restricted lesions in the left mid and poterior parietal regions.
Figure 2.
Figure 2.
Intermediate ring-enhancing lesions denoted by arrows in the right frontal lobe and the left half of the mesencephalon demonstrate mass effect. A short segment lesion in the left half of the cervical C4 spine is also highlighted.

References

    1. Dagher AP, Smirniotopoulos J.. Tumefactive demyelinating lesions. Neuroradiology. 1996;38(6):560–565. doi: 10.1007/BF00626098. - DOI - PubMed
    1. Ayrignac X, Carra-Dallière C, Labauge P.. Atypical inflammatory demyelinating lesions and atypical multiple sclerosis. Rev Neurol (Paris). 2018;174(6):408–418. doi: 10.1016/j.neurol.2018.03.007. - DOI - PubMed
    1. Frederick MC, Cameron MH.. Tumefactive demyelinating lesions in multiple sclerosis and associated disorders. Curr Neurol Neurosci Rep. 2016;16(3):26. doi: 10.1007/s11910-016-0626-9. - DOI - PubMed
    1. Hardy TA, Reddel SW, Barnett MH, Palace J, Lucchinetti CF, Weinshenker BG.. Atypical inflammatory demyelinating syndromes of the CNS. Lancet Neurol. 2016;15(9):967–981. doi: 10.1016/S1474-4422(16)30043-6. - DOI - PubMed
    1. Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014;48-49:134–142. doi: 10.1016/j.jaut.2014.01.022. - DOI - PubMed

Publication types

LinkOut - more resources